Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effectsMitsuhiro Kawakubo, Takayoshi Suganami, Marie Saka-Tanaka et al.|Scientific Reports|2020Cited by 72
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis–associated liver tumors in a novel murine modelNaoki Yoshioka, Takayoshi Suganami, Miyako Tanaka et al.|Biomedicine & Pharmacotherapy|2021Cited by 29